We've changed the way you complete courses

In response to user feedback we have simplified the way courses can be completed.

Until now you needed to complete the topics and modules in order, from start to finish. But from today you can complete them in any order you wish.

Just visit any topic that interests you, and when you are ready mark it as completed by clicking the green 'Mark complete' button at the bottom of the page.

Once you have completed all of the topics in a module an assessment will be provided for you.

Complete all the assessments to finish the course.

Thanks, I've got it! X

  • Achievement of sustained glycaemic control remains a challenge for many patients with type 1 diabetes (T1D)
  • Non-insulin–based adjunct treatments offer the potential to complement intensive insulin therapy with multiple daily injections or continuous subcutaneous insulin infusion in T1D
  • Several – like metformin and liraglutide – have been investigated but, to date, it is only SGLT-2 inhibitors that have begun to receive licences for use in people with type 1 diabetes

Click here to jump to the module in the “SGLT inhibitors” course on “SGLT inhibitors and type 1 diabetes”